SFG
CVS icon

SNS Financial Group’s CVS Health CVS Stock Holding History

SNS Financial Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$870K Sell
12,110
-104
-0.9% -$8.01K 0.07% 92
2025
Q4 		$969K Sell
12,214
-375
-3% -$29.6K 0.08% 86
2025
Q3 		$949K Sell
12,589
-199
-2% -$13.6K 0.08% 88
2025
Q2 		$882K Buy
12,788
+311
+2% +$20.4K 0.08% 91
2025
Q1 		$845K Buy
12,477
+305
+3% +$18.3K 0.09% 93
2024
Q4 		$546K Sell
12,172
-2,613
-18% -$147K 0.06% 107
2024
Q3 		$930K Sell
14,785
-688
-4% -$40.1K 0.09% 93
2024
Q2 		$914K Buy
+15,473
New +$968K 0.1% 90
2019
Q1 		– Sell
-3,363
Closed -$220K – 195
2018
Q4 		$220K Sell
3,363
-39
-1% -$2.91K 0.05% 162
2018
Q3 		$268K Sell
3,402
-104
-3% -$7.43K 0.06% 145
2018
Q2 		$226K Buy
3,506
+30
+0.9% +$1.98K 0.06% 151
2018
Q1 		$216K Sell
3,476
-463
-12% -$33.2K 0.06% 146
2017
Q4 		$286K Buy
3,939
+354
+10% +$25.7K 0.07% 144
2017
Q3 		$292K Sell
3,585
-41
-1% -$3.24K 0.07% 134
2017
Q2 		$292K Sell
3,626
-395
-10% -$31.2K 0.08% 131
2017
Q1 		$316K Buy
+4,021
New +$321K 0.08% 134

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SNS Financial Group's CVS Position: Q1 2026 in Review

SNS Financial Group reduced its CVS Health (CVS) stake by 0.85% in Q1 2026, selling an estimated $8.01K and leaving 12,110 shares worth $870K. The position accounts for 0.07% of the portfolio, ranked #92.

SNS Financial Group first reported a position in CVS in Q1 2017 and has held it in 16 quarters since. The position peaked at $969K in Q4 2025. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • SNS Financial Group held 12,110 shares of CVS Health worth $870K as of Q1 2026.
  • SNS Financial Group sold 104 CVS Health shares in Q1 2026, an estimated $8.01K.
  • CVS Health made up 0.07% of SNS Financial Group's portfolio in Q1 2026, its #92 holding.
  • SNS Financial Group first reported a position in CVS Health in Q1 2017 and has held it in 16 quarters since.
  • SNS Financial Group's CVS Health position peaked at $969K in Q4 2025.
  • 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on SNS Financial Group's 13F filing for Q1 2026, filed 14 Apr 2026.